posted                      

quote:

---

March 23, 2006 03:55 PM ET
Aastrom Remedy Gets Orphan-Drug Status
advertisement


Aastrom Biosciences, Inc.(ASTM) Stock Quote, Chart, News

All Associated Press News
ANN ARBOR, Mich. (AP) - Shares of Aastrom Biosciences Inc., a stem-cell firm that makes tissue-regeneration products, surged on Thursday following an announcement that Food and Drug Administration granted orphan-drug designation to its proprietary Tissue Repair Cells as a treatment for osteonecrosis.

Orphan-drug status is given to medicines that treat rare diseases. Companies that develop them receive benefits including seven years of market exclusivity upon approval, as well as potential tax credits and grant funding and reduced filing fees.

---

quote:

---

04/10/06 1.65 1.67 1.56 1.57 -0.07 5212000 -4.27 %


Period Moving Average Price Change Percent Change Average Volume
5-Day 1.69 -0.35 -18.23% 5072740
20-Day 1.85 -0.11 -6.55% 3514615
50-Day 1.83 -0.51 -24.52% 2453498
100-Day 1.99 -0.59 -27.31% 1892495
200-Day 2.31 -1.22 -43.73% 2149523
YTD 1.90 -0.54 -25.59% 2125334

---

Posts: 21062 | From: Fort Worth | Registered: Apr 2005  |  IP: Logged |